PA Capital’s Zimmer Biomet ZBH Stock Holding History

PA Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$448K	Sell	3,388 -1,143	-25%	-$149K	0.31%	110
2020 Q2	$525K	Sell	4,531 -4,721	-51%	-$544K	0.38%	96
2020 Q1	$908K	Buy	9,252 +973	+12%	+$128K	0.8%	42
2019 Q4	$1.2M	Buy	8,279 +264	+3%	+$36.4K	1.06%	25
2019 Q3	$1.07M	Sell	8,015 -1,696	-17%	-$219K	1.05%	29
2019 Q2	$1.11M	Buy	9,711 +2,533	+35%	+$297K	1.01%	35
2019 Q1	$890K	Buy	7,178 +1,375	+24%	+$156K	0.79%	40
2018 Q4	$584K	Buy	+5,803	New	+$653K	0.62%	58

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PA Capital's ZBH Position: Q3 2020 in Review

PA Capital reduced its Zimmer Biomet (ZBH) stake by 25% in Q3 2020, selling an estimated $149K and leaving 3,388 shares worth $448K. The position accounts for 0.31% of the portfolio, ranked #110.

PA Capital first reported a position in ZBH in Q4 2018 and has held it in 8 quarters since. The position peaked at $1.2M in Q4 2019. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

PA Capital held 3,388 shares of Zimmer Biomet worth $448K as of Q3 2020.
PA Capital sold 1,143 Zimmer Biomet shares in Q3 2020, an estimated $149K.
Zimmer Biomet made up 0.31% of PA Capital's portfolio in Q3 2020, its #110 holding.
PA Capital first reported a position in Zimmer Biomet in Q4 2018 and has held it in 8 quarters since.
PA Capital's Zimmer Biomet position peaked at $1.2M in Q4 2019.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.